Literature DB >> 29561721

Calling for a Unified Redefinition of "Borderlineness": Commentary on Gunderson et al.

Carla Sharp1.   

Abstract

This commentary critically evaluates the usefulness of the standards employed by Gunderson et al. (2018) for theory evaluation and comparison and calls into question their adequacy, based both on the lack of scientific evidence supporting the assertions these standards imply and on the availability of alternative standard for theory evaluation and comparison. In so doing, the commentary calls for a redefinition of "borderlineness" as well as the use of standard criteria for theory evaluation and comparison.

Mesh:

Year:  2018        PMID: 29561721     DOI: 10.1521/pedi.2018.32.2.168

Source DB:  PubMed          Journal:  J Pers Disord        ISSN: 0885-579X


  4 in total

1.  Prevalence and comorbidity of borderline personality traits in the Quebec general population aged 12-14 years.

Authors:  Jean Marc Guilé; Elissa Zavaglia; Claude Berthiaume; Lise Bergeron
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2021-03-21       Impact factor: 4.328

Review 2.  Borderline personality disorder in adolescents: prevalence, diagnosis, and treatment strategies.

Authors:  Jean Marc Guilé; Laure Boissel; Stéphanie Alaux-Cantin; Sébastien Garny de La Rivière
Journal:  Adolesc Health Med Ther       Date:  2018-11-23

3.  Personality Functioning and Mentalizing in Patients With Subthreshold or Diagnosed Borderline Personality Disorder: Implications for ICD-11.

Authors:  Marie Zerafine Rishede; Sophie Juul; Sune Bo; Matthias Gondan; Stine Bjerrum Møeller; Sebastian Simonsen
Journal:  Front Psychiatry       Date:  2021-03-31       Impact factor: 4.157

4.  Latent profiles of patients with borderline pathology based on the alternative DSM-5 model for personality disorders.

Authors:  Dominick Gamache; Claudia Savard; Philippe Leclerc; Maude Payant; Alexandre Côté; Jonathan Faucher; Mireille Lampron; Marc Tremblay
Journal:  Borderline Personal Disord Emot Dysregul       Date:  2021-02-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.